|
Insider Trading: Sgx Pharmaceuticals, Inc.
Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Sgx Pharmaceuticals, Inc. in the last 24 months are illustrated in figures 1 and 2. Table 1 shows the monthly insider trading data of Sgx Pharmaceuticals, Inc. since year 2005. Table 2 shows the detailed insider transactions of Sgx Pharmaceuticals, Inc. since 2005.
The reporting company's ticker symbol is SGXP.
The reporting company's CIK number is 1125603.
The total value of stock buying since 2005 is $6,142,520.
The total value of stock sales is $198,956.
The total value of stock exercises is $0.
1 year stock price chart,
1 day stock price chart
opopp opopopop
Figure 1. Monthly insider transaction values at Sgx Pharmaceuticals, Inc. (SGXP) in the past 24 months.
The trade values of insider stock buys, sales, and option exercises are in logarithmic scale
as shown on the right axis labels.
The detailed monthly and daily insider transactions are listed in the 2 tables below.
09 10 11 12 01 2007 02 03 04 05 06 07 08 09 10 11 12 01 2008 02 03 04 05 06 07 08 -
Figure 2. Average prices of insider buys, sales, and option exercises at Sgx Pharmaceuticals, Inc. (SGXP) in the past 24 months. See table 2 for insider transaction details.
09 10 11 12 01 2007 02 03 04 05 06 07 08 09 10 11 12 01 2008 02 03 04 05 06 07 08 -
Table 1. Monthly summaries of insider stock purchases, sales, and option exercises
for Sgx Pharmaceuticals, Inc. (SGXP).
Trading Period
year-month |
Insider Buying
Shares Value ($) |
Insider Sales
Shares Value ($) |
Option Exercises
Shares Value ($) |
| 2008-08 | 0 | 0 | 1,562 | 4,638 | 3,125 | 0 |
| 2008-07 | 1,298,100 | 3,939,898 | 1,562 | 3,634 | 3,125 | 0 |
| 2008-06 | 1,105,257 | 1,602,622 | 1,562 | 2,342 | 3,125 | 0 |
| 2008-05 | 0 | 0 | 1,562 | 2,248 | 3,125 | 0 |
| 2008-04 | 0 | 0 | 1,562 | 1,977 | 3,125 | 0 |
| 2008-03 | 0 | 0 | 3,124 | 12,556 | 6,251 | 0 |
| 2008-02 | 0 | 0 | 1,562 | 6,599 | 3,125 | 0 |
| 2008-01 | 0 | 0 | 1,562 | 7,489 | 3,125 | 0 |
| 2007-12 | 0 | 0 | 1,562 | 7,496 | 3,125 | 0 |
| 2007-11 | 0 | 0 | 1,562 | 9,059 | 3,125 | 0 |
| 2007-10 | 0 | 0 | 1,562 | 9,856 | 3,125 | 0 |
| 2007-09 | 0 | 0 | 1,562 | 9,632 | 3,125 | 0 |
| 2007-08 | 0 | 0 | 1,562 | 10,195 | 3,125 | 0 |
| 2007-07 | 0 | 0 | 1,562 | 8,887 | 3,125 | 0 |
| 2007-06 | 0 | 0 | 1,562 | 8,158 | 3,125 | 0 |
| 2007-05 | 0 | 0 | 1,562 | 7,985 | 3,125 | 0 |
| 2007-04 | 0 | 0 | 1,562 | 7,523 | 3,125 | 0 |
| 2007-03 | 0 | 0 | 1,562 | 8,090 | 3,125 | 0 |
| 2007-02 | 0 | 0 | 1,562 | 7,231 | 3,125 | 0 |
| 2007-01 | 0 | 0 | 10,156 | 35,330 | 20,312 | 0 |
| 2006-12 | 0 | 0 | 9,375 | 28,031 | 18,750 | 0 |
| 2006-02 | 100,000 | 600,000 | 0 | 0 | 0 | 0 |
Table 2. Detailed insider stock purchases, sales, and option exercises
for Sgx Pharmaceuticals, Inc. (SGXP)
| Trade Date |
Insider Name |
Trade Type |
Shares |
Price ($) |
Value ($) |
| 2008-08-15 | Reich Siegfried (VP, Drug Discovery) | Sale | 781 | 2.98 | 2,327 |
| 2008-08-15 | Reich Siegfried (VP, Drug Discovery) | Option Exercise | 1,562 | .00 | 0 |
| 2008-08-05 | Myers W Todd (CFO) | Sale | 781 | 2.96 | 2,311 |
| 2008-08-05 | Myers W Todd (CFO) | Option Exercise | 1,563 | .00 | 0 |
| 2008-07-15 | Reich Siegfried (VP, Drug Discovery) | Sale | 781 | 3.06 | 2,385 |
| 2008-07-15 | Reich Siegfried (VP, Drug Discovery) | Option Exercise | 1,563 | .00 | 0 |
| 2008-07-11 | Bvf Inc/il (Other) | Purchase | 12,500 | 3.07 | 38,372 |
| 2008-07-10 | Bvf Inc/il (Other) | Purchase | 403,200 | 3.03 | 1,221,615 |
| 2008-07-09 | Bvf Inc/il (Other) | Purchase | 800,300 | 3.04 | 2,434,112 |
| 2008-07-08 | Bvf Inc/il (Other) | Purchase | 82,100 | 2.99 | 245,799 |
| 2008-07-07 | Myers W Todd (CFO) | Sale | 781 | 1.60 | 1,249 |
| 2008-07-07 | Myers W Todd (CFO) | Option Exercise | 1,562 | .00 | 0 |
| 2008-06-18 | Bvf Inc/il (Other) | Purchase | 1,105,257 | 1.45 | 1,602,622 |
| 2008-06-16 | Reich Siegfried (VP, Drug Discovery) | Sale | 781 | 1.65 | 1,288 |
| 2008-06-16 | Reich Siegfried (VP, Drug Discovery) | Option Exercise | 1,562 | .00 | 0 |
| 2008-06-05 | Myers W Todd (CFO) | Sale | 781 | 1.35 | 1,054 |
| 2008-06-05 | Myers W Todd (CFO) | Option Exercise | 1,563 | .00 | 0 |
| 2008-05-15 | Reich Siegfried (VP, Drug Discovery) | Sale | 781 | 1.45 | 1,132 |
| 2008-05-15 | Reich Siegfried (VP, Drug Discovery) | Option Exercise | 1,563 | .00 | 0 |
| 2008-05-05 | Myers W Todd (CFO) | Sale | 781 | 1.43 | 1,116 |
| 2008-05-05 | Myers W Todd (CFO) | Option Exercise | 1,562 | .00 | 0 |
| 2008-04-15 | Reich Siegfried (VP, Drug Discovery) | Sale | 781 | 1.19 | 929 |
| 2008-04-15 | Reich Siegfried (VP, Drug Discovery) | Option Exercise | 1,562 | .00 | 0 |
| 2008-04-07 | Myers W Todd (CFO) | Sale | 781 | 1.34 | 1,048 |
| 2008-04-07 | Myers W Todd (CFO) | Option Exercise | 1,563 | .00 | 0 |
| 2008-03-17 | Reich Siegfried (VP, Drug Discovery) | Sale | 1,562 | 4.01 | 6,262 |
| 2008-03-17 | Reich Siegfried (VP, Drug Discovery) | Option Exercise | 3,126 | .00 | 0 |
| 2008-03-05 | Myers W Todd (CFO) | Sale | 781 | 4.05 | 3,163 |
| 2008-03-05 | Myers W Todd (CFO) | Option Exercise | 1,562 | .00 | 0 |
| 2008-02-15 | Reich Siegfried (VP, Drug Discovery) | Sale | 781 | 4.05 | 3,163 |
| 2008-02-15 | Reich Siegfried (VP, Drug Discovery) | Option Exercise | 1,562 | .00 | 0 |
| 2008-02-05 | Myers W Todd (CFO) | Sale | 781 | 4.40 | 3,436 |
| 2008-02-05 | Myers W Todd (CFO) | Option Exercise | 1,563 | .00 | 0 |
| 2008-01-15 | Reich Siegfried (VP, Drug Discovery) | Sale | 781 | 4.44 | 3,467 |
| 2008-01-15 | Reich Siegfried (VP, Drug Discovery) | Option Exercise | 1,563 | .00 | 0 |
| 2008-01-07 | Myers W Todd (CFO) | Sale | 781 | 5.15 | 4,022 |
| 2008-01-07 | Myers W Todd (CFO) | Option Exercise | 1,562 | .00 | 0 |
| 2007-12-17 | Reich Siegfried (VP, Drug Discovery) | Sale | 781 | 4.75 | 3,709 |
| 2007-12-17 | Reich Siegfried (VP, Drug Discovery) | Option Exercise | 1,562 | .00 | 0 |
| 2007-12-05 | Myers W Todd (CFO) | Sale | 781 | 4.85 | 3,787 |
| 2007-12-05 | Myers W Todd (CFO) | Option Exercise | 1,563 | .00 | 0 |
| 2007-11-15 | Reich Siegfried (VP, Drug Discovery) | Sale | 781 | 5.10 | 3,983 |
| 2007-11-15 | Reich Siegfried (VP, Drug Discovery) | Option Exercise | 1,563 | .00 | 0 |
| 2007-11-05 | Myers W Todd (CFO) | Sale | 781 | 6.50 | 5,076 |
| 2007-11-05 | Myers W Todd (CFO) | Option Exercise | 1,562 | .00 | 0 |
| 2007-10-15 | Reich Siegfried (VP, Drug Discovery) | Sale | 781 | 6.42 | 5,014 |
| 2007-10-15 | Reich Siegfried (VP, Drug Discovery) | Option Exercise | 1,562 | .00 | 0 |
| 2007-10-05 | Myers W Todd (CFO) | Sale | 781 | 6.20 | 4,842 |
| 2007-10-05 | Myers W Todd (CFO) | Option Exercise | 1,563 | .00 | 0 |
| 2007-09-17 | Reich Siegfried (VP, Drug Discovery) | Sale | 781 | 6.20 | 4,842 |
| 2007-09-17 | Reich Siegfried (VP, Drug Discovery) | Option Exercise | 1,563 | .00 | 0 |
| 2007-09-05 | Myers W Todd (CFO) | Sale | 781 | 6.13 | 4,790 |
| 2007-09-05 | Myers W Todd (CFO) | Option Exercise | 1,562 | .00 | 0 |
| 2007-08-15 | Reich Siegfried (VP, Drug Discovery) | Sale | 781 | 6.42 | 5,017 |
| 2007-08-15 | Reich Siegfried (VP, Drug Discovery) | Option Exercise | 1,562 | .00 | 0 |
| 2007-08-06 | Myers W Todd (CFO) | Sale | 781 | 6.63 | 5,178 |
| 2007-08-06 | Myers W Todd (CFO) | Option Exercise | 1,563 | .00 | 0 |
| 2007-07-16 | Reich Siegfried (VP, Drug Discovery) | Sale | 781 | 6.05 | 4,725 |
| 2007-07-16 | Reich Siegfried (VP, Drug Discovery) | Option Exercise | 1,563 | .00 | 0 |
| 2007-07-05 | Myers W Todd (CFO) | Sale | 781 | 5.33 | 4,162 |
| 2007-07-05 | Myers W Todd (CFO) | Option Exercise | 1,562 | .00 | 0 |
| 2007-06-15 | Reich Siegfried (VP, Drug Discovery) | Sale | 781 | 5.15 | 4,019 |
| 2007-06-15 | Reich Siegfried (VP, Drug Discovery) | Option Exercise | 1,562 | .00 | 0 |
| 2007-06-05 | Myers W Todd (CFO) | Sale | 781 | 5.30 | 4,139 |
| 2007-06-05 | Myers W Todd (CFO) | Option Exercise | 1,563 | .00 | 0 |
| 2007-05-15 | Reich Siegfried (VP, Drug Discovery) | Sale | 781 | 5.18 | 4,049 |
| 2007-05-15 | Reich Siegfried (VP, Drug Discovery) | Option Exercise | 1,563 | .00 | 0 |
| 2007-05-07 | Myers W Todd (CFO) | Sale | 781 | 5.04 | 3,936 |
| 2007-05-05 | Myers W Todd (CFO) | Option Exercise | 1,562 | .00 | 0 |
| 2007-04-16 | Reich Siegfried (VP, Drug Discovery) | Sale | 781 | 5.02 | 3,923 |
| 2007-04-16 | Reich Siegfried (VP, Drug Discovery) | Option Exercise | 1,562 | .00 | 0 |
| 2007-04-05 | Myers W Todd (CFO) | Sale | 781 | 4.61 | 3,600 |
| 2007-04-05 | Myers W Todd (CFO) | Option Exercise | 1,563 | .00 | 0 |
| 2007-03-15 | Reich Siegfried (VP, Drug Discovery) | Sale | 781 | 5.53 | 4,318 |
| 2007-03-15 | Reich Siegfried (VP, Drug Discovery) | Option Exercise | 1,563 | .00 | 0 |
| 2007-03-05 | Myers W Todd (CFO) | Sale | 781 | 4.83 | 3,772 |
| 2007-03-05 | Myers W Todd (CFO) | Option Exercise | 1,562 | .00 | 0 |
| 2007-02-15 | Reich Siegfried (VP, Drug Discovery) | Sale | 781 | 5.36 | 4,186 |
| 2007-02-15 | Reich Siegfried (VP, Drug Discovery) | Option Exercise | 1,562 | .00 | 0 |
| 2007-02-05 | Myers W Todd (CFO) | Sale | 781 | 3.90 | 3,045 |
| 2007-02-05 | Myers W Todd (CFO) | Option Exercise | 1,563 | .00 | 0 |
| 2007-01-16 | Reich Siegfried (Vice President, Drug Discovery) | Sale | 9,375 | 3.50 | 32,812 |
| 2007-01-16 | Reich Siegfried (Vice President, Drug Discovery) | Option Exercise | 18,750 | .00 | 0 |
| 2007-01-05 | Myers W Todd (Chief Financial Officer) | Sale | 781 | 3.22 | 2,518 |
| 2007-01-05 | Myers W Todd (Chief Financial Officer) | Option Exercise | 1,562 | .00 | 0 |
| 2006-12-05 | Myers W Todd (Chief Financial Officer) | Sale | 9,375 | 2.99 | 28,031 |
| 2006-12-05 | Myers W Todd (Chief Financial Officer) | Option Exercise | 18,750 | .00 | 0 |
| 2006-02-06 | Lathi Vijay K (Director) | Purchase | 100,000 | 6.00 | 600,000 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above tables cannot be completely guaranteed as to their accuracy.
For more insider trading information of Sgx Pharmaceuticals, Inc. (symbol SGXP,
CIK number 1125603) see
the Securities and Exchange Commission (SEC) website.
|
|
